Bimonthly, Established in 1959
Open access journal


“Depression Up 60% in a Decade” – 2025 CDC Report Finds Soaring Prevalence and 1 in 10 Adults on Antidepressants

A new CDC analysis of national survey data finds that depression rates among U.S. adults have surged by nearly 60% in the past ten years. The report highlights widening demographic gaps, increasing reliance on antidepressants, and urgent calls for broader access to mental health care.

Key Points

  • Depression prevalence among U.S. adults rose from 7% in 2015 to over 11% in 2025, a relative increase of almost 60%.
  • One in 10 adults now reports current use of antidepressants, with higher rates among women, middle-aged adults, and those with chronic conditions.
  • The findings underscore rising demand for mental health services and the need for systemic policy responses, not just individual treatment.

Study at a Glance

  • Journal & Date: CDC National Health and Nutrition Examination Survey (NHANES) data release, April 16, 2025 — CDC Press Release
  • Study Design & Population: Cross-sectional study, nationally representative survey of U.S. adults (N ≈ 30,000 over the past decade).
  • Primary Outcomes: Prevalence of depression symptoms (PHQ-9 scores) and self-reported use of antidepressant medications.

What’s New vs Prior Evidence

Past CDC reports documented steady increases in depression, but the scale of the current surge is unprecedented. The COVID-19 pandemic amplified stressors such as job loss, social isolation, and grief, while access to timely mental health support lagged. Compared with earlier surveys, the new report shows sharper increases among younger adults and women, pointing to persistent vulnerabilities in these groups. Another notable change is the normalization of antidepressant use, which now extends to one in ten adults, reflecting both broader prescribing practices and patient willingness to seek help. Unlike past data snapshots, the 2025 release provides a full decade view, offering a clearer picture of trends and highlighting areas where preventive measures are failing.

Expert Comment

Kathleen Ethier, Director of the CDC’s Division of Adolescent and School Health, comments:

“These findings should be a wake-up call. Depression is no longer a marginal issue, it is a central public health challenge affecting millions of Americans. The rise in antidepressant use shows that people are seeking care, which is positive, but it also signals strain on healthcare systems and gaps in non-pharmacological supports. We must expand access to therapy, community-based resources, and upstream prevention strategies, especially for groups at highest risk. It is not enough to treat depression once it occurs. The priority has to be prevention and building resilience.”

Who Could Benefit

  • Patients and families who gain validation that their struggles reflect national trends, not individual failings.
  • Clinicians who can use these data to advocate for more resources and integrated mental health services.
  • Policymakers who need evidence to allocate funding toward telehealth, workforce expansion, and equitable access.
  • Researchers who can use the longitudinal NHANES dataset to explore causal factors and intervention points.

Limitations & Uncertainties

  • Cross-sectional data cannot prove causation or explain why depression is rising.
  • Self-reported antidepressant use may be underestimated or influenced by recall bias.
  • PHQ-9 screening identifies symptoms, not necessarily clinical diagnoses, which may inflate prevalence compared with medical records.
  • Data may not fully capture marginalized populations (e.g., undocumented immigrants, institutionalized individuals) who face high risk but limited representation.

What Happens Next

CDC officials emphasize the importance of monitoring depression trends as part of broader public health surveillance. Policymakers are expected to use the findings to guide investments in telehealth, mental health workforce development, and integration of behavioral health into primary care. Researchers will also push to understand drivers of the rise, including social media use, economic stressors, and long-term impacts of the pandemic.

Summary

Depression is rising quickly in the U.S. A new CDC report shows nearly 60% more adults have symptoms now than ten years ago, and about one in ten takes antidepressant medication. The numbers highlight an urgent need for better access to care and prevention efforts.

Glossary

  • Depression (Major Depressive Disorder): A medical condition marked by persistent sadness, loss of interest, and other symptoms lasting at least two weeks.
  • NHANES (National Health and Nutrition Examination Survey): A long-running U.S. program that collects health and nutrition data from thousands of people to track public health trends.
  • PHQ-9: A nine-item questionnaire widely used to screen for depression symptoms in clinical and research settings.
  • Cross-Sectional Study: A study that looks at data from a population at a single point in time, useful for measuring prevalence but not causality.

References

  1. Centers for Disease Control and Prevention. (2025, April 16). Depression among U.S. adults: New findings from NHANES 2015–2025. National Center for Health Statistics Press Release. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2025/20250416.htm
  2. Brody, D. J., Pratt, L. A., & Hughes, J. P. (2018). Prevalence of depression among adults aged 20 and over: United States, 2013–2016. NCHS Data Brief, 303, 1–8. https://www.cdc.gov/nchs/products/databriefs/db303.htm
  3. Pratt, L. A., Brody, D. J., & Gu, Q. (2017). Antidepressant use among persons aged 12 and over: United States, 2011–2014. NCHS Data Brief, 283, 1–8. https://www.cdc.gov/nchs/products/databriefs/db283.htm